$PHBI tiny float of 867,000 shares which should alleviate selling pressure and act as a strong catalyst to increase its share price substantially. Pharmagreen looks to be on its way to a Billion dollar market cap as it trades like its Cannabis industry peers. One can easily foresee the company having one of the largest market caps in the Cannabis sector and this is the most compelling Cannabis stock we have come across in Private Equity Markets history. The stock has recently pulled back from 2.00 to .75 offering investors a tremendous opportunity to pick up shares at the bottom. The company is currently working on uplisting to the OTCQB which will build confidence within the investment community. It will be a easy process for the company to uplist because they have already been an audited company for more than a year. PHBI is set to multiply rapidly from this level. 10.00 a share seems very possible due to the 200 million dollar backlog of orders from thousands of industrial hemp farmers who have struck gold with the "CBD Dana" seedlings. We expect the 2020 growing season will provide major revenues and profits to PHBI and soon "CBD Dana" will expand its presence in the United States.
https://www.privateequitymarkets.us/newslette...is-indutry
https://www.privateequitymarkets.us/newslette...is-indutry
